US Stock MarketDetailed Quotes

LCTX Lineage Cell Therapeutics

Watchlist
  • 0.585
  • -0.056-8.73%
Trading Nov 21 15:24 ET
110.55MMarket Cap-5854P/E (TTM)

Lineage Cell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
203.29%3.78M
-56.34%1.41M
-39.48%1.44M
-39.16%8.95M
9.03%2.09M
-58.44%1.25M
-29.17%3.23M
-54.44%2.39M
277.39%14.7M
99.48%1.92M
Operating revenue
203.29%3.78M
-56.34%1.41M
-39.48%1.44M
-39.16%8.95M
9.03%2.09M
-58.44%1.25M
-29.17%3.23M
-54.44%2.39M
277.39%14.7M
99.48%1.92M
Cost of revenue
-77.51%38K
-65.35%44K
-17.65%98K
-7.83%671K
150.98%256K
-28.09%169K
-40.93%127K
-32.39%119K
-48.95%728K
-50.00%102K
Gross profit
247.35%3.74M
-55.97%1.36M
-40.63%1.35M
-40.79%8.27M
1.05%1.83M
-61.02%1.08M
-28.58%3.1M
-55.21%2.27M
465.79%13.98M
139.81%1.81M
Operating expense
-2.58%7.58M
-10.97%7.23M
-10.12%8.01M
-9.56%33.01M
-3.05%8.19M
-2.89%7.78M
-5.25%8.12M
-22.24%8.91M
-29.38%36.5M
-70.85%8.45M
Selling and administrative expenses
9.13%4.41M
2.68%4.36M
5.78%5M
-23.13%17.3M
-1.38%4.29M
-8.62%4.04M
-19.37%4.25M
-44.22%4.72M
23.59%22.51M
-1.72%4.35M
-General and administrative expense
9.13%4.41M
2.68%4.36M
5.78%5M
-23.13%17.3M
-1.38%4.29M
-8.62%4.04M
-19.37%4.25M
-44.22%4.72M
23.59%22.51M
-1.72%4.35M
Research and development costs
-15.24%3.17M
-25.95%2.87M
-28.08%3.01M
12.28%15.71M
-4.82%3.91M
4.15%3.74M
17.29%3.87M
40.06%4.19M
-58.76%13.99M
-83.44%4.1M
Operating profit
42.73%-3.84M
-16.78%-5.87M
-0.29%-6.66M
-9.83%-24.73M
4.17%-6.36M
-27.69%-6.71M
-18.66%-5.02M
-3.85%-6.64M
54.24%-22.52M
76.49%-6.64M
Net non-operating interest income expense
-8.31%397K
21.20%463K
12.68%462K
96.50%1.63M
2.54%404K
12.76%433K
649.02%382K
40,900.00%410K
41,350.00%829K
13,033.33%394K
Non-operating interest income
-8.31%397K
21.20%463K
12.68%462K
96.50%1.63M
2.54%404K
12.76%433K
649.02%382K
40,900.00%410K
41,350.00%829K
--394K
Other net income (expense)
149.89%442K
34.22%-369K
-1,536.00%-359K
95.68%-178K
1,163.25%1.24M
-25.14%-886K
78.41%-561K
103.58%25K
-169.39%-4.12M
-151.77%-117K
Gain on sale of security
149.83%442K
40.03%-388K
16.90%-359K
91.16%-174K
447.96%1.79M
-280.69%-887K
8.49%-647K
15.95%-432K
-150.10%-1.97M
67.36%-515K
Other non- operating income (expenses)
----
-77.91%19K
----
99.81%-4K
-237.69%-548K
100.21%1K
104.55%86K
348.37%457K
-244.82%-2.15M
-77.94%398K
Income before tax
58.07%-3M
-10.96%-5.77M
-5.65%-6.56M
9.80%-23.28M
25.90%-4.71M
-28.39%-7.16M
23.28%-5.2M
12.49%-6.21M
40.35%-25.81M
77.29%-6.36M
Income tax
0
0
0
-433.27%-1.8M
0
0
0
-1.8M
541K
0
Net income
58.07%-3M
-10.96%-5.77M
-48.91%-6.56M
18.50%-21.48M
25.90%-4.71M
-17.04%-7.16M
23.28%-5.2M
37.91%-4.4M
39.10%-26.35M
78.20%-6.36M
Net income continuous Operations
58.07%-3M
-10.96%-5.77M
-48.91%-6.56M
18.50%-21.48M
25.90%-4.71M
-17.04%-7.16M
23.28%-5.2M
37.91%-4.4M
39.10%-26.35M
78.20%-6.36M
Minority interest income
168.75%33K
-150.00%-13K
50.00%-16K
108.75%7K
862.50%61K
-2.13%-48K
236.84%26K
-433.33%-32K
68.13%-80K
96.00%-8K
Net income attributable to the parent company
57.33%-3.03M
-10.15%-5.76M
-49.63%-6.54M
18.22%-21.49M
24.85%-4.78M
-17.15%-7.11M
22.68%-5.23M
38.31%-4.37M
38.93%-26.27M
78.08%-6.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
57.33%-3.03M
-10.15%-5.76M
-49.63%-6.54M
18.22%-21.49M
24.85%-4.78M
-17.15%-7.11M
22.68%-5.23M
38.31%-4.37M
38.93%-26.27M
78.08%-6.35M
Basic earnings per share
50.00%-0.02
0.00%-0.03
-33.33%-0.04
20.00%-0.12
33.33%-0.02
0.00%-0.04
25.00%-0.03
25.00%-0.03
42.31%-0.15
82.35%-0.03
Diluted earnings per share
50.00%-0.02
0.00%-0.03
-33.33%-0.04
20.00%-0.12
33.33%-0.02
0.00%-0.04
25.00%-0.03
25.00%-0.03
42.31%-0.15
82.35%-0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 203.29%3.78M-56.34%1.41M-39.48%1.44M-39.16%8.95M9.03%2.09M-58.44%1.25M-29.17%3.23M-54.44%2.39M277.39%14.7M99.48%1.92M
Operating revenue 203.29%3.78M-56.34%1.41M-39.48%1.44M-39.16%8.95M9.03%2.09M-58.44%1.25M-29.17%3.23M-54.44%2.39M277.39%14.7M99.48%1.92M
Cost of revenue -77.51%38K-65.35%44K-17.65%98K-7.83%671K150.98%256K-28.09%169K-40.93%127K-32.39%119K-48.95%728K-50.00%102K
Gross profit 247.35%3.74M-55.97%1.36M-40.63%1.35M-40.79%8.27M1.05%1.83M-61.02%1.08M-28.58%3.1M-55.21%2.27M465.79%13.98M139.81%1.81M
Operating expense -2.58%7.58M-10.97%7.23M-10.12%8.01M-9.56%33.01M-3.05%8.19M-2.89%7.78M-5.25%8.12M-22.24%8.91M-29.38%36.5M-70.85%8.45M
Selling and administrative expenses 9.13%4.41M2.68%4.36M5.78%5M-23.13%17.3M-1.38%4.29M-8.62%4.04M-19.37%4.25M-44.22%4.72M23.59%22.51M-1.72%4.35M
-General and administrative expense 9.13%4.41M2.68%4.36M5.78%5M-23.13%17.3M-1.38%4.29M-8.62%4.04M-19.37%4.25M-44.22%4.72M23.59%22.51M-1.72%4.35M
Research and development costs -15.24%3.17M-25.95%2.87M-28.08%3.01M12.28%15.71M-4.82%3.91M4.15%3.74M17.29%3.87M40.06%4.19M-58.76%13.99M-83.44%4.1M
Operating profit 42.73%-3.84M-16.78%-5.87M-0.29%-6.66M-9.83%-24.73M4.17%-6.36M-27.69%-6.71M-18.66%-5.02M-3.85%-6.64M54.24%-22.52M76.49%-6.64M
Net non-operating interest income expense -8.31%397K21.20%463K12.68%462K96.50%1.63M2.54%404K12.76%433K649.02%382K40,900.00%410K41,350.00%829K13,033.33%394K
Non-operating interest income -8.31%397K21.20%463K12.68%462K96.50%1.63M2.54%404K12.76%433K649.02%382K40,900.00%410K41,350.00%829K--394K
Other net income (expense) 149.89%442K34.22%-369K-1,536.00%-359K95.68%-178K1,163.25%1.24M-25.14%-886K78.41%-561K103.58%25K-169.39%-4.12M-151.77%-117K
Gain on sale of security 149.83%442K40.03%-388K16.90%-359K91.16%-174K447.96%1.79M-280.69%-887K8.49%-647K15.95%-432K-150.10%-1.97M67.36%-515K
Other non- operating income (expenses) -----77.91%19K----99.81%-4K-237.69%-548K100.21%1K104.55%86K348.37%457K-244.82%-2.15M-77.94%398K
Income before tax 58.07%-3M-10.96%-5.77M-5.65%-6.56M9.80%-23.28M25.90%-4.71M-28.39%-7.16M23.28%-5.2M12.49%-6.21M40.35%-25.81M77.29%-6.36M
Income tax 000-433.27%-1.8M000-1.8M541K0
Net income 58.07%-3M-10.96%-5.77M-48.91%-6.56M18.50%-21.48M25.90%-4.71M-17.04%-7.16M23.28%-5.2M37.91%-4.4M39.10%-26.35M78.20%-6.36M
Net income continuous Operations 58.07%-3M-10.96%-5.77M-48.91%-6.56M18.50%-21.48M25.90%-4.71M-17.04%-7.16M23.28%-5.2M37.91%-4.4M39.10%-26.35M78.20%-6.36M
Minority interest income 168.75%33K-150.00%-13K50.00%-16K108.75%7K862.50%61K-2.13%-48K236.84%26K-433.33%-32K68.13%-80K96.00%-8K
Net income attributable to the parent company 57.33%-3.03M-10.15%-5.76M-49.63%-6.54M18.22%-21.49M24.85%-4.78M-17.15%-7.11M22.68%-5.23M38.31%-4.37M38.93%-26.27M78.08%-6.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 57.33%-3.03M-10.15%-5.76M-49.63%-6.54M18.22%-21.49M24.85%-4.78M-17.15%-7.11M22.68%-5.23M38.31%-4.37M38.93%-26.27M78.08%-6.35M
Basic earnings per share 50.00%-0.020.00%-0.03-33.33%-0.0420.00%-0.1233.33%-0.020.00%-0.0425.00%-0.0325.00%-0.0342.31%-0.1582.35%-0.03
Diluted earnings per share 50.00%-0.020.00%-0.03-33.33%-0.0420.00%-0.1233.33%-0.020.00%-0.0425.00%-0.0325.00%-0.0342.31%-0.1582.35%-0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data